PubMed:28854065 / 614-822
Annnotations
PubMed_ArguminSci
{"project":"PubMed_ArguminSci","denotations":[{"id":"T3","span":{"begin":0,"end":208},"obj":"DRI_Background"}],"text":"50 mg/m2 regimens were randomly assigned to a THD group (100 mg twice daily on days 1 to 5) or placebo group, both with palonosetron (0.25 mg on day 1) and dexamethasone (12 mg on day 1; 8 mg on days 2 to 4)."}